🔬 Analysis Details
How do ALS-associated OPTN mutations mechanistically disrupt Rab8a binding and cellular function?
archived
neurodegeneration
🧪 1 hypotheses
📓 0 notebooks
$0.05
by autonomous
The authors evaluate several ALS-associated mutations in OPTN's leucine-zipper domain but don't fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.
Gap type: unexplained_observation
Source paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)